Published in Nephrol Dial Transplant on February 18, 2009
Stat5 signaling specifies basal versus stress erythropoietic responses through distinct binary and graded dynamic modalities. PLoS Biol (2012) 1.59
Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact. Eur J Clin Pharmacol (2010) 0.84
A population-based study comparing biosimilar versus originator erythropoiesis-stimulating agent consumption in 6,117 patients with renal anaemia. Eur J Clin Pharmacol (2012) 0.84
Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo. Nano Lett (2016) 0.81
Hybrid mass spectrometry approaches in glycoprotein analysis and their usage in scoring biosimilarity. Nat Commun (2016) 0.80
Methotrexate Is a JAK/STAT Pathway Inhibitor. PLoS One (2015) 0.79
Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing. J Cell Sci (2003) 2.46
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights. Kidney Int (2012) 2.38
Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol Biol Cell (2003) 2.11
Role of blood platelets in infection and inflammation. J Interferon Cytokine Res (2002) 2.01
Moderate altitude but not additional endurance training increases markers of oxidative stress in exhaled breath condensate. Eur J Appl Physiol (2009) 1.99
Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J (2004) 1.90
Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res (2005) 1.65
Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway. FEBS Lett (2002) 1.60
Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element. Biochem J (2005) 1.45
Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact. Blood (2005) 1.41
Inhibition of erythropoietin gene expression signaling involves the transcription factors GATA-2 and NF-kappaB. FASEB J (2002) 1.00
Human hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietin. FASEB J (2007) 0.98
Thrombopoietin production in wild-type and interleukin-6 knockout mice with acute inflammation. J Interferon Cytokine Res (2005) 0.98
Lack of functional erythropoietin receptors of cancer cell lines. Int J Cancer (2008) 0.94
Preclinical studies of erythropoietin receptor expression in tumour cells: impact on clinical use of erythropoietic proteins to correct cancer-related anaemia. Eur J Cancer (2006) 0.91
Impact of erythropoietin on intensive care unit patients. Transfus Med Hemother (2013) 0.91
Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. J Clin Endocrinol Metab (2002) 0.89
Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood (2003) 0.88
VEGF production by primary human renal proximal tubular cells: requirement of HIF-1, PI3-kinase and MAPKK-1 signaling. Cell Physiol Biochem (2005) 0.86
Thrombopoietin: the novel hepatic hormone. News Physiol Sci (2002) 0.86
Effects of chloroquine treatment on circulating erythropoietin and inflammatory cytokines in acute Plasmodium falciparum malaria. Ann Hematol (2008) 0.83
The Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT/HIF-1β) is influenced by hypoxia and hypoxia-mimetics. Cell Physiol Biochem (2013) 0.82
Progress in detecting cell-surface protein receptors: the erythropoietin receptor example. Ann Hematol (2013) 0.81
Stabilisation and knockdown of HIF--two distinct ways comparably important in radiotherapy. Cell Physiol Biochem (2011) 0.81
Nuclear-cytoplasmatic shuttling of proteins in control of cellular oxygen sensing. J Mol Med (Berl) (2015) 0.81
Erythropoietin and the skin: a role for epidermal oxygen sensing? Bioessays (2009) 0.80
Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF. Strahlenther Onkol (2011) 0.80
Recombinant EPO production--points the nephrologist should know. Nephrol Dial Transplant (2007) 0.79
Austrian Moderate Altitude Study (AMAS 2000) - fluid shifts, erythropoiesis, and angiogenesis in patients with metabolic syndrome at moderate altitude (congruent with 1700 m). Eur J Appl Physiol (2002) 0.79
Problems in identifying functional erythropoietin receptors in cancer tissue. J Clin Oncol (2007) 0.79
A multi-center study on the regenerative effects of erythropoietin in burn and scalding injuries: study protocol for a randomized controlled trial. Trials (2013) 0.79
Erythropoietin augments survival of glioma cells after radiation and temozolomide. Int J Radiat Oncol Biol Phys (2008) 0.78
'O', erythropoietin carbamoylation versus carbamylation. Nephrol Dial Transplant (2008) 0.77
The elusive erythropoietin receptor. Nephrol Dial Transplant (2012) 0.75
Intolerability of cobalt salt as erythropoietic agent. Drug Test Anal (2013) 0.75
Erythropoietin production: Molecular mechanisms of the antagonistic actions of cyclic adenosine monophosphate and interleukin-1. FEBS Lett (2006) 0.75
Thrombopoietin production in human hepatic cell cultures (HepG2) is resistant to IFN-alpha, IFN-beta, and IFN-gamma treatment. J Interferon Cytokine Res (2002) 0.75
Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia. Onkologie (2005) 0.75
Vascular endothelial growth factor response to exogenous chorionic gonadotropic hormone in the luteal phase of women with a history of severe ovarian hyperstimulation syndrome. Arch Gynecol Obstet (2006) 0.75
Does erythropoietin modulate human hair follicle melanocyte activities in situ? Exp Dermatol (2009) 0.75
Prolyl-4-Hydroxylase 2 Potentially Contributes to Hepatocellular Carcinoma-Associated Erythrocytosis by Maintaining Hepatocyte Nuclear Factor-4α Expression. Cell Physiol Biochem (2015) 0.75